Glycemic Variability
9
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (9)
Changes in Person-reported Outcomes and Behavior Using the Accu-Chek SmartGuide CGM and Predict App
Comparison of Liposomal Bupivacaine Paravertebral Nerve Block Versus Intercostal Nerve Block on Postoperative Glycemic Variability in Patients Undergoing Minimally Invasive Pulmonary Resection: A Randomized Controlled Non-Inferiority Trial
Glycemic Variability During Pregnancy After Bariatric Surgery
Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS
Glycemic Variability: Prognostic Impact on Acute Ischemic Stroke
Impact of Dietary Fat and Menstrual Cycle Phases in Type 1 Diabetes
Glycaemic Responses to a Food Intake Sequence Intervention in Free-living Elite Female Athletes
Diabetes Type One in Pregnancy and Continuos Glucose Monitoring
Glucose Variability in Pregnancy Complicated by Diabetes